Early Career and Rise of the Junk Bond Market
Michael Milken built Drexel Burnham Lambert's high-yield bond department into the dominant force in corporate finance during the 1980s, earning the nickname "junk bond king." He pioneered the use of speculative-grade bonds to fund leveraged buyouts and hostile takeovers, reshaping merger activity and creating a new asset class that bypassed traditional bank lending. His desk at Drexel generated billions in fees and made him one of the highest-paid Wall Street figures of the era, with annual compensation reportedly exceeding $500 million at the peak of the market Forbes.
The junk bond market he helped build became a critical source of capital for companies with weak balance sheets, enabling deals that would have been impossible through conventional financing. By the mid-1980s, Drexel Burnham Lambert controlled an estimated 70 percent of the high-yield bond market, with Milken's Los Angeles office serving as the epicenter of trading and deal-making activity.
Indictment, Guilty Plea, and Prison Sentence
In 1989, the U.S. Securities and Exchange Commission filed civil charges against Milken for securities fraud, insider trading, and filing false reports, leading to his resignation from Drexel Burnham Lambert and a settlement that included a lifetime ban from the securities industry SEC. In 1990, Milken pleaded guilty to six felony counts of securities fraud and conspiracy, agreeing to pay $600 million in fines and restitution and to cooperate with prosecutors investigating broader Wall Street misconduct.
He was sentenced to 10 years in federal prison, serving approximately two years at the Federal Correctional Institution in Lompoc, California, before his release in 1993. The case became a landmark in enforcement of financial regulations and led to major reforms in how the SEC monitors high-yield bond markets and insider trading, with the Milken Institute later founded to focus on medical research and economic policy Milken Institute.
Current Role, Philanthropy, and Net Worth
After prison, Milken shifted his focus to philanthropy and medical research, founding the Milken Institute and the FasterCures initiative to accelerate treatments for diseases such as cancer, Alzheimer's, and COVID-19. He has donated hundreds of millions to research institutions, universities, and public health programs, and the Milken Institute now operates centers in multiple cities and advises governments on economic development and healthcare innovation Forbes.
Michael Milken's estimated net worth remains in the hundreds of millions, derived from his post-prison investments, the Milken Institute's endowment, and ongoing advisory roles in finance and healthcare. He continues to be referenced in discussions of Wall Street ethics, financial regulation, and the long-term consequences of insider trading, with his legacy serving as a cautionary case study in business schools and regulatory training programs worldwide.